Skip to main content
KOWA CO.,LTD. logo

KOWA CO.,LTD. — Investor Relations & Filings

Ticker · 7807 ISIN · JP3292900002 LEI · 353800AVPSFI46030813 T Manufacturing
Filings indexed 69 across all filing types
Latest filing 2024-09-19 Transaction in Own Shar…
Country JP Japan
Listing T 7807

About KOWA CO.,LTD.

https://www.kowa.co.jp/eng/

Kowa Co., Ltd. is a diversified company that integrates manufacturing and trading operations across several business units. The company's trading arm manages the import, export, and sale of a wide range of products, including textiles, machinery, and construction materials. In the life science and healthcare sector, Kowa develops, manufactures, and markets pharmaceuticals, over-the-counter health products, and medical devices, with a notable specialization in ophthalmic diagnostic equipment. The company is also a prominent manufacturer of high-performance optical products, such as binoculars and spotting scopes, under its Prominar brand. Additionally, Kowa operates a hospitality business, managing hotels and other related services.

Recent filings

Filing Released Lang Actions
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Transaction in Own Shares Classification · 100% confidence The document title is "自己株券買付状況報告書" which translates to 'Report on the Status of Treasury Stock Acquisition'. The basis cited is "金融商品取引法第24条の6第1項" (Financial Instruments and Exchange Act Article 24-6, Paragraph 1). The content details the acquisition status of treasury stock (own shares) during a specific reporting period (August 1 to August 31, 2024). This directly corresponds to the definition of reporting the company buying back or selling its own shares, which is classified as 'Transaction in Own Shares' (POS). The document is a formal report detailing the transaction status, not an announcement of a report (RPA) or a general regulatory filing (RNS).
2024-09-19 Japanese
確認書
Regulatory Filings Classification · 95% confidence The document is a 'Confirmation Letter' (確認書) filed under the Financial Instruments and Exchange Act, which serves as an officer certification regarding the accuracy of a previously filed corrected Annual Securities Report (有価証券報告書). According to the 'CERTIFICATION RULE', documents that are primarily officer certifications or attestations should be classified as Regulatory Filings (RNS), even if they reference a specific report type. FY 2024
2024-07-18 Japanese
訂正有価証券報告書-第37期(2023/03/01-2024/02/29)
Annual Report Classification · 100% confidence The document is a '訂正有価証券報告書' (Amended Securities Report) filed with the Kinki Finance Bureau in Japan. It contains detailed financial data, including consolidated management indicators for the 37th fiscal year (ending February 29, 2024). While it is an amendment, it functions as an official annual financial report (10-K equivalent in the Japanese regulatory context). FY 2024
2024-07-18 Japanese
確認書
Report Publication Announcement Classification · 100% confidence The document text explicitly contains the title "第1四半期報告書" (First Quarter Report) and specifies the period covered: "第38期第1四半期(自 2024年3月1日 至 2024年5月31日)". It also mentions confirmation of the report's appropriateness under financial instruments laws, submitted to the Kinki Local Finance Bureau. This content structure is characteristic of a comprehensive quarterly financial report, which aligns with the definition of an Interim / Quarterly Report (IR). The document length is very short (565 chars), but the content is the substance of the report confirmation itself, not just an announcement of publication, making IR more appropriate than RPA/RNS, as it contains the core assertion about the report's contents for the specified period.
2024-07-12 Japanese
四半期報告書-第38期第1四半期(2024/03/01-2024/05/31)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for the first quarter of the 38th fiscal period (March 1, 2024, to May 31, 2024). It contains detailed financial statements, including the consolidated balance sheet, income statement, and comprehensive income statement, as well as management analysis and segment information. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). Q1 2025
2024-07-12 Japanese
訂正臨時報告書
Major Shareholding Notification Classification · 100% confidence The document is titled "訂正臨時報告書" (Corrected Extraordinary Report) and explicitly states it is being filed based on Article 24-5, Paragraph 4 of the Financial Instruments and Exchange Act and Article 19, Paragraph 2, Item 3 of the Cabinet Office Ordinance on Disclosure of Corporate Information. The content details a change in the parent company following a share buyback program, which is a significant corporate event requiring an extraordinary report in Japan. This structure and content align best with a general regulatory filing that reports a specific, non-periodic event, which falls under the scope of 'Regulatory Filings' (RNS) or potentially a specific type of extraordinary report not explicitly listed. Given the options, 'RNS' (Regulatory Filings) is the most appropriate general category for mandatory, event-driven disclosures that are not standard periodic reports (10-K, IR) or specific announcements like dividends or management changes. The document is a formal submission to the Kinki Local Finance Bureau (近畿財務局).
2024-05-31 Japanese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.